Cost Effectiveness and Resource Allocation

Papers
(The H4-Index of Cost Effectiveness and Resource Allocation is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Vaccination distribution by community pharmacists under the COVID-19 vaccine appointment system in Taiwan57
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness34
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?29
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer28
Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis28
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial26
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea24
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening23
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency23
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model21
Economic burden of knee joint replacement in Iran21
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran21
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model19
Temporal trend of comorbidity and increasing impacts on mortality, length of stay, and hospital costs of first stroke in Tianjin, North of China18
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique18
Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis18
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”17
Can integrated care improve the efficiency of hospitals? Research based on 200 Hospitals in China17
0.030493974685669